CTSH — Cognizant Technology Solutions Corporation stock price, charts and financials
QT45Cognizant Technology Solutions CorporationCognizant Technology Solutions Corporation (NASDAQ: CTSH) is a Technology company in the Information Technology Services industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | S&P 500 | P/E | 12.52 | EPS (ttm) | 4.65 | Insider Own | 0.16% | Shs Outstand | 450.44M | Perf Week | -8.19% |
| Market Cap | 26.22B | Forward P/E | 9.22 | EPS next Y | 6.31 | Insider Trans | -1.94% | Shs Float | 449.21M | Perf Month | -0.19% |
| Enterprise Value | 27.11B | PEG | 4.39 | EPS next Q | 1.44 | Inst Own | - | Short Float | 7.92% | Perf Quarter | 9.94% |
| Income | 2.22B | P/S | 1.21 | EPS this Y | 23.70% | Inst Trans | - | Short Ratio | 3.16 | Perf Half Y | -7.59% |
| Sales | 21.64B | P/B | 1.81 | EPS next Y | 9.76% | ROA | 10.66% | Short Interest | 35.60M | Perf YTD | -29.88% |
| Book/sh | 32.11 | P/C | 24.94 | EPS next 5Y | 2.85% | ROE | 14.94% | 52W High | 87.03 -33.13% | Perf Year | -18.25% |
| Cash/sh | 2.33 | P/FCF | 10.80 | EPS past 3/5Y | 1.05% 12.10% | ROIC | 12.32% | 52W Low | 37.08 56.96% | Perf 3Y | -18.86% |
| Dividend Est. | 1.32 (2.27%) | EV/EBITDA | 6.84 | Sales past 3/5Y | 2.80% 4.86% | Gross Margin | 32.00% | Volatility | 3.13% 3.21% | Perf 5Y | -23.73% |
| Dividend TTM | 1.30 (2.23%) | EV/Sales | 1.25 | EPS Y/Y TTM | 3.10% | Oper. Margin | 15.76% | ATR (14) | 2.22 | Perf 10Y | 0.61% |
| Dividend Ex-Date | Aug 18, 2026 | Quick Ratio | 2.18 | Sales Y/Y TTM | 9.66% | Profit Margin | 10.26% | RSI (14) | 46.54 | Recom | 2.67 |
| Dividend Gr. 3/5Y | 4.71% 7.10% | Current Ratio | 2.18 | EPS Q/Q | 4.58% | SMA20 | -5.06% | Beta | 0.86 | Target Price | 64.77 |
| Payout | 27.84% | Debt/Eq | 0.10 | Sales Q/Q | 4.50% | SMA50 | 9.31% | Rel Volume | 0.61 | Prev Close | 59.92 |
| Employees | 356,700 | LT Debt/Eq | 0.09 | Earnings | Nov 04 | SMA200 | -7.10% | Avg Volume | 10.21M | Price | 58.20 |
| IPO Date | Jun 19, 1998 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -0.54% 0.00% | Net Debt/EBITDA | 0.27 | Volume | 6,227,059 | Change | -2.87% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-06-26 | Reiterated | Mizuho Securities | Neutral | $68 → $64 |
| Jul-30-26 | Reiterated | Robert W. Baird | $55 → $68 | |
| Jul-30-26 | Reiterated | Susquehanna | Positive | $88 → $82 |
| Jul-30-26 | Reiterated | Morgan Stanley | Equal Weight | $44 → $51 |
| Jul-27-26 | Reiterated | Guggenheim | Buy | $100 → $65 |
| Jul-24-26 | Reiterated | RBC Capital | Sector Perform | $82 → $47 |
| Jul-10-26 | Reiterated | Deutsche Bank | Hold | $70 → $55 |
| Jul-10-26 | Reiterated | Robert W. Baird | $72 → $55 | |
| Jul-10-26 | Reiterated | Wells Fargo | Overweight | $98 → $61 |
| Jun-23-26 | Reiterated | Morgan Stanley | Equal Weight | $63 → $44 |
Cognizant Technology Solutions Corporation functions as a global professional services firm, delivering a comprehensive suite of consulting, technology, and outsourcing solutions across North America, Europe, and other international markets. Its operations are structured into four primary divisions: Financial Services, Healthcare, Products and Resources, and Communications, Media and Technology. Within the Financial Services sector, Cognizant provides advanced services such as enhancing customer experiences, implementing robotic process automation (RPA), and leveraging analytics and artificial intelligence (AI) to address needs in areas like digital lending, fraud prevention, and modern payment systems. For its Healthcare clients, the company focuses on navigating industry shifts toward consumer-centric models, outcome-based agreements, and digital health initiatives, striving to deliver an integrated, seamless, and patient-focused omnichannel experience. Furthermore, Cognizant assists in optimizing operations across various functions, including clinical development, pharmacovigilance, manufacturing, claims management, enrollment procedures, membership administration, and billing processes. Its clientele in this domain spans healthcare providers, payers, and life sciences organizations, encompassing pharmaceutical, biotechnology, and medical device firms. In the Products and Resources segment, the company develops solutions tailored for manufacturers, retailers, and entities within the travel and hospitality sectors, alongside those engaged in logistics, energy, and utility services. Within the Communications, Media and Technology division, Cognizant supports businesses in creating digital content, crafting personalized user experiences, and expediting digital engineering efforts. This includes serving information, media, entertainment, communications, and technology enterprises. Established in 1994, the company maintains its primary corporate office in Teaneck, New Jersey.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 21,642 | 21,108 | 19,736 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 14,716 | 13,991 | 12,958 | — | — | — | — | — | — | |
| Gross Profit | 6,926 | 7,117 | 6,778 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 3,154 | 3,240 | 3,223 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 362 | 348 | 663 | — | — | — | — | — | — | |
| Operating Income | 3,410 | 3,529 | 2,892 | — | — | — | — | — | — | |
| Interest Expense | 36 | 37 | 54 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 141 | 221 | 115 | — | — | — | — | — | — | |
| Net Income Before Taxes | 3,515 | 3,713 | 2,953 | — | — | — | — | — | — | |
| Income Taxes | 1,287 | 1,483 | 713 | — | — | — | — | — | — | |
| Consolidated Net Income | 2,220 | 2,230 | 2,240 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 2,228 | 2,230 | 2,240 | — | — | — | — | — | — | |
| Net Income | 2,220 | 2,230 | 2,240 | — | — | — | — | — | — | |
| EPS (Recurring) | 4.66 | 4.56 | 4.52 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 4.66 | 4.56 | 4.52 | — | — | — | — | — | — | |
| EPS (Diluted) | 4.65 | 4.55 | 4.51 | — | — | — | — | — | — | |
| EBITDA | 3,962 | 4,173 | 3,534 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 12.52 | 18.24 | 17.05 | — | — | — | — | — | — | |
| Price To Sales Ratio | 1.25 | 1.89 | 1.93 | — | — | — | — | — | — | |
| Gross Margin | 32.00 | 33.72 | 34.34 | — | — | — | — | — | — | |
| Operating Margin | 15.76 | 16.72 | 14.65 | — | — | — | — | — | — | |
| Net Margin | 10.26 | 10.56 | 11.35 | — | — | — | — | — | — | |
| Shares Outstanding | 466 | 481 | 496 | — | — | — | — | — | — | |
| Market Capitalization | 27,121 | 39,923 | 38,142 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Kim John Sunshin | CLO, CAO & Corporate Secretary | Sep 02 '26 | Sale | 63.37 | 2,500 | 158,431 | 39,909 | Sep 04 |
| Varrier Rajesh | President Operations CMD India | Sep 01 '26 | Option Exercise | 0.00 | 544 | 0 | 10,672 | Sep 03 |
| Dalal Jatin P | Chief Financial Officer | Sep 01 '26 | Option Exercise | 0.00 | 6,448 | 0 | 52,559 | Sep 03 |
| Singisetti Ravi Kumar | Chief Executive Officer | Sep 01 '26 | Option Exercise | 0.00 | 15,092 | 0 | 137,750 | Sep 03 |
| Diaz Kathryn | Chief People Officer | Sep 01 '26 | Option Exercise | 0.00 | 2,136 | 0 | 24,779 | Sep 03 |
| Kim John Sunshin | CLO, CAO & Corporate Secretary | Sep 01 '26 | Option Exercise | 0.00 | 4,402 | 0 | 44,794 | Sep 03 |
| Ayyar Balu Ganesh | President - APJ and ISG | Sep 01 '26 | Option Exercise | 0.00 | 2,058 | 0 | 114,230 | Sep 03 |
| Kerdman Alina | SVP, Controller & CAO | Sep 01 '26 | Option Exercise | 0.00 | 621 | 0 | 1,469 | Sep 03 |
| Gummadi Surya | President - Americas | Sep 01 '26 | Option Exercise | 0.00 | 5,224 | 0 | 42,424 | Sep 03 |
| Kerdman Alina | SVP, Controller & CAO | Aug 31 '26 | Sale | 63.34 | 144 | 9,121 | 848 | Sep 02 |
| Kim John Sunshin | CLO, CAO & Corporate Secretary | Aug 03 '26 | Sale | 57.05 | 2,500 | 142,625 | 40,392 | Aug 05 |
| Dalal Jatin P | Chief Financial Officer | Aug 03 '26 | Sale | 55.76 | 12,000 | 669,168 | 46,111 | Aug 05 |
| Kerdman Alina | SVP, Controller & CAO | Jul 01 '26 | Option Exercise | 0.00 | 207 | 0 | 1,197 | Jul 06 |
| Kerdman Alina | SVP, Controller & CAO | Jul 01 '26 | Sale | 39.82 | 137 | 5,455 | 992 | Jul 06 |
| Kerdman Alina | SVP, Controller & CAO | Jun 15 '26 | Option Exercise | 0.00 | 199 | 0 | 1,188 | Jun 17 |